The promoter regions of most eukaryotic genes contain binding sites for more than one transcriptional activator and these activators often bind cooperatively to promoters. The most common type of cooperativity is supported by direct protein-protein interactions. Recent studies have shown that proteins that do not specifically interact with one another can bind cooperatively to chromatin in vitro, probably by the localized destabilization of nucleosome structure by one factor, facilitating binding of another to a nearby site. This mechanism does not require that the transcription factors have activation domains. We have examined whether this phenomenon occurs in vivo.
Background
Most eukaryotic genes have complex promoters that contain binding sites for different positive and negative regulatory factors [1] and these transcription factors can interact functionally with one another. A particularly common observation is that the effect of two or more transcriptional activators working in concert on a promoter is greater than the sum of their individual activities. In many cases, this synergy is consistent with the observation of cooperative binding of the transcription factors to DNA in vitro [2] [3] [4] [5] , but many observations of synergistic effects in vivo have been reported for activators that do not bind cooperatively to naked DNA templates in vitro. This has led to the proposal of fundamentally different models for synergistic activation in which either protein-protein interactions or protein-DNA interactions are limiting [6] [7] [8] . Most of these models propose either that high-level transcription requires multiple interactions of the activator with general transcription factors which can only be satisfied by several activators, or that different activators may stimulate different partially rate-limiting steps, leading to 'kinetic synergy' [9] . Experiments using DNA bound by core nucleosomes have shown that proteins that do not interact with one another specifically and that are unrelated -and therefore unlikely to bind to the same sites on DNAnonetheless bind cooperatively to closely spaced DNA sites in vitro [10] . This may be due to localized destabilization of nucleosome structure by one factor, which enhances the ability of a second binding protein to compete with histones for a nearby site [11, 12] . In larger DNA substrates with multiple nucleosomes, binding of one high-affinity factor could act as a positioning element, making it much more likely that a nearby site would remain nucleosome free. This 'non-traditional' explanation for cooperative binding of transcription factors to promoters could explain, at least in part, many observations of synergistic activation. Recently, Chavez and Beato [13] used footprinting experiments to demonstrate a clear-cut case of cooperative binding in vivo of two activators that do not bind naked DNA cooperatively in vitro; their work supports the biological relevance of using nucleosomebound DNA in experiments studying cooperative binding in vitro.
In this report, we examine in more detail the mechanism of cooperative binding between unrelated transcription factors, using the Saccharomyces cerevisiae Gal4 protein (Gal4p), a potent activator of genes involved in galactose metabolism, and derivatives of the Escherichia coli LexA protein. These proteins do not interact with one another directly and, as expected, do not bind cooperatively to naked DNA templates in vitro. It is shown that Gal4p and LexA protein derivatives do bind cooperatively to plasmids bearing the appropriate sites in yeast cells, however. There appear to be two distinct mechanisms for cooperativity: one is 'short-range' and may be the result of nucleosome destabilization or repositioning as discussed above. The other can operate over distances of at least several hundred base pairs and requires that both factors have potent activation domains. The biological implications of these data are discussed.
Results and discussion
Gal4p and LexA bind to DNA cooperatively in yeast S. cerevisiae Gal4p is a prototypical transcriptional activator that stimulates the expression of several genes involved in galactose metabolism [14, 15] . Recently, a simple method was developed to measure binding of Gal4p to DNA quantitatively in vivo. This 'plasmid titration' assay [16, 17] takes advantage of the fact that expression of the native MEL1 gene, which encodes α-galactosidase, is limited by binding of the low abundance Gal4p to the single lowaffinity upstream activation sequence (UAS) in the promoter. Introduction of plasmids bearing Gal4p-binding sites decreased the expression of the MEL1 gene (Figure 1a ) because the plasmid-borne binding sites compete for limiting endogenous Gal4p. The magnitude of the inhibitory effect was related linearly to the number of plasmid molecules introduced and the affinity of Gal4p for the plasmid-borne site (H.E. Xu, Q. Li, A. Vonica, T.K. and S.A.J., unpublished observations). For example, transformation of yeast with plasmids that carry a single, high-affinity [17, 18] , consensus Gal4p-binding site (cUAS; [19] ) and are maintained at about either 12 or 25 copies per cell, resulted in inhibition of MEL1 transcription by 10% and 20%, respectively (Figure 1b) . When the plasmids carried the low-affinity [17, 18] MEL1 UAS (UAS MEL1 ), very little inhibition of MEL1 expression was observed (0% and 3%, respectively; Figure 1b ).
The same titration assay was used to ask whether the nearby binding of the bacterial LexA protein would influence the binding of Gal4p to its recognition site. The experiments were conducted in a yeast strain overexpressing the LexA DNA-binding domain (LexA DBD) [20] . This protein binds its cognate operator (O Lex ) with high affinity, but does not activate transcription in yeast. As LexA is a bacterial protein, it seems highly unlikely that it makes specific contacts with Gal4p of the type that would support cooperative DNA binding. As shown in Figure 1b , however, titration plasmids carrying the UAS MEL1 and O Lex sequences separated by 29 base pairs were much more effective competitors of MEL1 expression than those carrying only UAS MEL1 : binding of Gal4p to UAS MEL1 was stimulated 6-10-fold. Quantitative Southern blots demonstrated that the average copy number of the titration plasmids was unaffected by the presence of the O Lex (data not shown). Plasmids bearing the O Lex site, but no Gal4p recognition sequence, had little effect on MEL1 expression (Figure 1b) . These data argue that Gal4p and LexA DBD bind to the titration plasmids cooperatively. Gal4p and the LexA DNA-binding domain (LexA DBD) bind to plasmid DNA cooperatively in yeast. (a) The plasmid titration assay, which measures the decrease in MEL1 expression due to the introduction of plasmids carrying Gal4p-binding sites. In this experiment, the effect of introducing plasmids bearing either the low-affinity Gal4p-binding site UAS MEL1 or the high-affinity cUAS site was assessed in cases where the plasmids either did or did not also have a LexA-binding site (O Lex ) located 29 bp away from the Gal4p-binding site. (b) Results from plasmid titration assays probing the effect of a nearby LexA DBD-O Lex complex on the affinity of Gal4p for cUAS or UAS MEL1 . Experiments were done with plasmids that were identical except for the copy number at which they were maintained. The LexA DBD-O Lex complex stimulates binding to UAS MEL1 strongly and has a slight stimulatory effect on Gal4p-cUAS association. This is consistent with cooperative binding. When MEL1 expression was not inhibited, the α-galactosidase activity was about 600 units. Mean values are given above bars; the data showed 5% variation. ability of Gal4p to occupy a high-affinity UAS, as cooperativity is less important for occupancy of a strong site. Indeed, when the weak MEL1 site was replaced with the high-affinity cUAS site, the presence of a nearby LexA DBD-O Lex complex had less than a twofold effect on Gal4p occupancy ( Figure 1b) .
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A nearby LexA DBD-O Lex complex stimulates Gal4p-mediated transcription
To look for further evidence of cooperative binding of LexA DBD and Gal4p and to ask whether the effects observed in the plasmid titration experiment are relevant to promoter occupancy, the experiment shown in Figure 2 was carried out. The same yeast strain was transformed with a lacZ reporter plasmid whose promoter contains single UAS MEL1 and O Lex sites separated by 29 base pairs. The level of β-galactosidase expression supported by this plasmid was compared with that obtained using a reporter plasmid that lacked the O Lex site, but was otherwise identical. The presence of a nearby LexA DBD-O Lex complex was found to stimulate Gal4p-mediated lacZ expression by about fourfold when transcription was driven by the weak UAS MEL1 (Figure 2b ). This is in reasonable agreement with the 6-10-fold increase in DNA-binding affinity observed in the plasmid titration assay. As expected, almost no β-galactosidase activity was observed when the plasmid contained only an O Lex site. These data provide further evidence that a nearby LexA DBD-DNA complex stimulates Gal4p binding in vivo and demonstrate that this effect can accentuate the level of Gal4p-mediated transcription supported by a low-affinity binding site. They also show how a protein that is itself not an activator (LexA DBD) can contribute significantly to expression of the target gene by facilitating occupancy of the promoter by a true activator.
The most common mechanism for cooperative DNA binding involves direct association between the two DNAbinding proteins. Though this seems unlikely for yeast Gal4p and bacterial LexA DBD, in vitro DNA-binding experiments were carried out to test this possibility. A DNA fragment corresponding to the UAS MEL1 + O Lex promoter element used in the experiment shown in Figure 2 was radiolabeled. This fragment was then incubated with a constant amount of yeast extract from a gal4 -LexA DBD + strain and increasing amounts of extract from a GAL4 + lexA DBD -strain. Extracts were used, rather than purified proteins, in case another protein somehow contributed to cooperative binding. If Gal4p and LexA DBD bind DNA cooperatively by interacting with each other, then Gal4p should have a higher affinity for the LexA DBD-DNA complex than for naked DNA; however, gel retardation experiments revealed that Gal4p bound naked DNA and the LexA DBD-DNA complex with approximately equal affinities (Figure 3 ), confirming the expectation that Gal4p and LexA DBD do not bind to naked DNA cooperatively.
Evidence for two distinct mechanisms of cooperative binding between Gal4p and LexA derivatives
A distinguishing feature of the simple nucleosome-mediated cooperativity observed by Adams and Workman [10] in vitro was that the degree of cooperativity was strongly distance dependent, but was not affected by the presence or absence of an activation domain. To ask if the cooperativity observed in vivo between LexA DBD and Gal4p can be explained completely by this mechanism, these parameters were investigated. Figure 4 (open squares) illustrates that cooperative DNA binding by LexA DBD and Gal4p in vivo was diminished considerably when the sites were separated by 200 base pairs and essentially abolished at 400 base pairs, consistent with a simple core nucleosome destabilization model.
Fusion of the activation domain of the herpes simplex virus VP16 protein [21] [22] [23] to LexA DBD, however, increased the degree of cooperativity about twofold over that observed using LexA DBD alone ( Figure 4 ; the O Lex and UAS sites were separated by 29 base pairs). Note that the data in Figure 4 were normalized to a control in which the titration plasmid carried neither a Gal4p-nor LexAbinding site, thus correcting for the somewhat lower level of transcriptional activity due to general squelching by the
Figure 2
The reporter gene shown in LexA-VP16 fusion protein. Thus, the differences in MEL1 inhibition in the presence and absence of the VP16 activation domain cannot be ascribed to a generic inhibitory effect due to titration of some limiting transcription factor. Again, DNA-binding experiments using LexA-VP16 and lysates made from Gal4p-expressing yeast showed that these proteins do not bind to naked DNA cooperatively in vitro (data not shown). In striking contrast to LexA DBD, LexA-VP16 exhibited highly cooperative binding with Gal4p in vivo even when UAS MEL1 and O Lex were separated by 200 or 400 base pairs ( Figure 4 , closed diamonds). These results are not predicted by a simple core-nucleosome-displacement model of the type shown in Figure 5 .
Thus, the data argue that there are at least two mechanisms for cooperative binding in vivo of Gal4p and proteins containing LexA DBD. One mechanism has a sharp dependence on the separation between the DNA sites involved and does not require that LexA DBD be fused to an activation domain. The other mechanism is distance insensitive, at least over the 400 base-pair range examined, and requires that both proteins have an activation domain. The latter mechanism supports a somewhat higher degree of cooperativity. Neither requires direct and specific interactions between the proteins. Gel retardation experiments reveal that Gal4p and LexA DBD do not bind naked DNA cooperatively in vitro. Increasing amounts of extract from a GAL4 + lexA DBD -strain were incubated with the UAS + O Lex probe in the absence (lanes 2-5) or presence (lanes 7-10) of a constant amount of extract from a gal4 -LexA DBD + strain. Sufficient gal4 -LexA DBD + extract was added to approximately half-saturate the O Lex site. PhosphorImager quantitation of the free DNA probe and of DNA-LexA complexes is shown below the autoradiogram and reveals that Gal4p binds to the naked DNA and the DNA-LexA complex with about equal affinity. No cooperativity was observed. The Gal4p-containing complexes were unstable at higher Gal4p concentrations presumably because Gal4p can form higher-order complexes that dissociate during electrophoresis. Gal4ptrunc-DNA is a complex between DNA and an amino-terminal proteolytic fragment of Gal4p as determined by antibody supershifts (data not shown). The asterisk indicates an unidentified complex. 
Figure 4
Dependence of cooperativity on the distance (in bp) between UAS MEL1 and O Lex , as measured by plasmid titration. The results shown were obtained from at least three separate experiments in which the plasmids were present at an average copy number per cell of 12. For each set of experiments -using cells expressing high levels of either LexA DBD or a fusion protein comprising LexA DBD and the activation domain of VP16 (LexA-VP16) -the α-galactosidase activities were normalized to those in a control experiment, using the same cells, in which the titration plasmid contained neither a Gal4p-nor a LexA-binding site. This corrected for the moderate amount of squelching due to high-level expression of LexA-VP16. Therefore, the higher level of MEL1 inhibition in the presence of LexA-VP16 was not due to general squelching. The results argue that there are at least two mechanisms that support non-traditional cooperative binding: a 'short-range' mechanism that does not require the presence of an activation domain on the LexA protein and is strongly distance dependent, and a 'long-range' mechanism that requires the presence of the VP16 activation domain. 
Possible molecular mechanisms for cooperative binding
In considering models for these cooperative binding phenomena, it is assumed that LexA DBD and LexA-VP16 essentially saturate the plasmid sites in vivo. This assumption is supported by the fact that these proteins were expressed from the strong ADH1 promoter, LexA DBD has a very high affinity for O Lex and LexA-VP16 is a potent activator in yeast cells [24] . It is also consistent with in vivo footprinting data (S.V. and T.K., unpublished observations) which, while not very quantitative, show occupancy of O Lex . The situation in these experiments is therefore one of a stably bound LexA chimera helping to recruit Gal4p to a low-affinity site. As mentioned, the short-range mechanism is probably due to the fundamentally cooperative nature of two proteins binding to a single core nucleosome ( Figure 5) . A related possibility is that stable binding of LexA DBD creates a boundary that positions otherwise randomly situated nucleosomes on the plasmid in a way that promotes Gal4p binding to nearby sites.
Fusion of the activation domain of VP16 to LexA DBD doubles the magnitude of the observed cooperativity and, more importantly, renders cooperative binding insensitive to the distance between the Gal4p and LexA binding sites. There have been previous reports that the presence of an activation domain can enhance binding of a single transcriptional activator to simple promoters with sites for only that protein [16, 25] . The molecular basis of this effect is not completely clear, but it has been speculated that direct contacts between activation domains and transcription factors support cooperative binding of the polymerase II holoenzyme and the activator. As the activation domain of VP16 has been reported to interact with a histone acetylase complex [26, 27] , stable binding of the LexA-VP16 fusion to the O Lex site might modify the chromatin structure over an extended area, thus enhancing binding of Gal4p to its cognate UAS (Figure 6a ). It may also be that the activation domain of VP16 recruits the Swi/Snf chromatin remodeling complex [28] [29] [30] [31] , which is thought to facilitate transcription-factor binding to chromatinized DNA [32] [33] [34] [35] . Whether or not such a model is compatible with the observation that cooperativity is retained even when the protein binding sites are separated by several hundred base pairs is unclear, as the 'range' over which these chromatin remodeling machines might influence factor binding has not been studied carefully.
An alternative model, that different transcriptional activators have nonoverlapping targets in the polymerase II holoenzyme, has been proposed [6, 7] . If so, Gal4p and LexA-VP16 could contact one another indirectly via a 'protein bridge' (Figure 6b ), thus supporting cooperative binding. This kind of idea has been put forward to rationalize synergistic activation, but with the important difference that high-affinity DNA-protein interactions were proposed to support weak protein-protein contacts. If this model is operative in the experiments reported here, the opposite is true; strong protein-protein contacts help to anchor a weak Gal4p-DNA interaction. One argument against this model is that cooperativity was observed in the plasmid titration experiments even though there was no promoter near the Gal4p and LexA-VP16 binding sites. This argument is tempered, however, by the fact Figure 5 A possible activation-domain-independent mechanism to rationalize cooperative binding of Gal4p and LexA DBD in vivo. LexA is proposed to 'loosen' the structure of the nucleosome (brown) in the immediate vicinity of O Lex (dark gray box), facilitating binding of Gal4p to a nearby site. This type of model has been discussed previously [10, 12] . that the plasmid does contain a distant URA3 promoter which could harbor a holoenzyme complex that might interact with the activators. Northern blots of URA3 expression did not reveal any effect due to the presence of Gal4p and LexA-VP16 (data not shown), but this is not conclusive evidence against a bridged interaction involving a transcription complex at this promoter. Further investigation will be necessary to distinguish between various models for the mechanism of this cooperative activation-domain-dependent binding.
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Reporter gene experiments
Derivatives of pJLb, which contains a β-galactosidase gene under the control of a CYC1 core promoter, were used. The derivatives contained either a single O Lex (5′-GTACTGTATGTACATACAGTAC-3′), a single UAS MEL1 (5′-CGGCCATATGTCTTCCG-3′) or O Lex and UAS MEL1 separated by 29 bp. The sites were approximately 200 bp from the transcription start site. LexA DBD was expressed from the ADH1 promoter in pEG202 (gift from Roger Brent, Harvard Medical School). Plasmids were transformed into yeast strain Sc18 and grown in the appropriate media with 2% galactose, 3% glycerol and 2% lactic acid as the carbon source. β-galactosidase assays were performed as described [16] .
Plasmid titration assays
Plasmid titration assays were carried out as described previously [16] . The plasmids employed were derivatives of YEp352 (average copy number 12) and YEp351 (average copy number 25). Oligonucleotides containing either a single O Lex , a UAS MEL1 or a cUAS (5′-CGGAG-GACTGTCCTCCG-3′) site were inserted into these vectors. These derivatives were then employed to place an O Lex and either a cUAS or a UAS MEL1 site in the same vector. When both O Lex and UAS MEL1 sites were present, they were separated either by 29, 200 or 400 bp. The intervening DNA did not contain any native yeast sequences. Experiments involving LexA DBD were performed in Sc18 while experiments involving LexA-VP16 were performed in yeast strain 21R. When present, LexA DBD and LexA-VP16 were expressed from a plasmid under the control of the potent ADH1 promoter. The YEp-based titration plasmid together with the appropriate LexA-expressing plasmid were transformed into yeast and grown in the appropriate medium with 2% galactose, 3% glycerol and 2% lactic acid as the carbon source.
In vitro DNA-binding experiments
The probe was isolated as a 100 bp PCR fragment from the same reporter plasmid used for the in vivo experiments. The fragment was end-labeled with Klenow and α-[ 32 P]dATP and gel-purified. Gel shift conditions and extract preparation were as described previously [37] .
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